Literature DB >> 8607802

Diethyldithiocarbamate treatment up regulates manganese superoxide dismutase gene expression in rat liver.

S Borrello1, M E De Leo, M Landriscina, B Palazzotti, T Galeotti.   

Abstract

In vivo experiments demonstrate that rat liver manganese-containing superoxide dismutase (MnSOD) is up-regulated at the transcriptional level following the inactivation of copper-zinc superoxide dismutase (CuZnSOD). CuZnSOD activity was inhibited by the administration of the copper chelating agent diethyldithiocarbamate (DDC). This CuZnSOD inactivation is likely associated with an intracellular oxidative stress. Indeed the antioxidant N-acetyl-cysteine (NAC) completely prevents the MnSOD mRNA up-regulation observed after DDC administration. Evidence is also provided that an approximately 50% diminution of the total iron content in the tissue, which follows the in vivo administration of the iron chelator desferrioxamine (DESF), reduces the amount of MnSOD induction achieved by DDC treatment. Both NAC and DESF significantly down-regulate MnSOD gene expression also in normal untreated rat liver. While the observed inhibitory effect of NAC in MnSOD mRNA up-regulation can be ascribed mainly to its antioxidant property, iron chelation could act with an antioxidant effect and/or affecting some iron-dependent factor(s) possibly involved in MnSOD gene regulation. It is proposed that this metal could have a role among factors that sense and/or trigger transcription of the MnSOD gene.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8607802     DOI: 10.1006/bbrc.1996.0441

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Accumulation of manganese superoxide dismutase under metal-depleted conditions: proposed role for zinc ions in cellular redox balance.

Authors:  Kaoru Otsu; Yoshitaka Ikeda; Junichi Fujii
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

2.  Curdlan sulphate modulates protein synthesis and enhances NF-kappaB and C/EBP binding activity in HepG2 cells.

Authors:  A Guzdek; H Rokita
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.